Udayan Apte
- Hepatology top 0.5%
- Liver physiology and pathology 43
- Pharmacology top 0.2%
- Drug-Induced Hepatotoxicity and Protection 27
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 24
- Hepatitis B Virus Studies 9
- Cell Biology top 2%
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer 16
-
- Pancreatic function and diabetes 18
- Organ Transplantation Techniques and Outcomes 8
-
- Drug Transport and Resistance Mechanisms 17
- Co-authors
- Satdarshan P. MongaChad WaleskyBharat BhushanPallavi B. LimayeKartik ShankarTiangang LiGenea EdwardsPrachi Borude
- Cited by
- HepatologyPharmacologyEpidemiology
- Partner nations
- United StatesFranceChina
In The Last Decade
Udayan Apte
107 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 137
- Hepatology 1.6k
- Pharmacology 951
- Epidemiology 1.4k
- Cell Biology 596
- Molecular Biology 2.3k
Countries citing papers authored by Udayan Apte
This map shows the geographic impact of Udayan Apte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udayan Apte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udayan Apte more than expected).
Fields of papers citing papers by Udayan Apte
This network shows the impact of papers produced by Udayan Apte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udayan Apte. The network helps show where Udayan Apte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Udayan Apte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 79 | |
| 8 | 2019 | 17 | |
| 9 | 2018 | 38 | |
| 10 | 2017 | 86 | |
| 11 | 2017 | 37 | |
| 12 | 2016 | 55 | |
| 13 | 2014 | 142 | |
| 14 | 2010 | 66 | |
| 15 | 2009 | 101 | |
| 16 | 2008 | 71 | |
| 17 | 2006 | 77 | |
| 18 | 2006 | 73 | |
| 19 | 2006 | 116 | |
| 20 | Trypsin inhibitors in Indian foodstuffs. 5. Effect of raw double bean (Faba vulgaris M. ) and double bean trypsin inhibitor on the growth of rats. | 1958 | 2 |
About Udayan Apte
Udayan Apte is a scholar working on Hepatology, Pharmacology, Epidemiology, Cell Biology and Oncology, having authored 109 papers that have together received 5.5k indexed citations. Recurring topics across this work include Liver physiology and pathology (43 papers), Drug-Induced Hepatotoxicity and Protection (27 papers), Liver Disease Diagnosis and Treatment (24 papers), Pancreatic function and diabetes (18 papers), Drug Transport and Resistance Mechanisms (17 papers), Wnt/β-catenin signaling in development and cancer (16 papers), Hepatitis B Virus Studies (9 papers) and Organ Transplantation Techniques and Outcomes (8 papers). The work is most often cited by research in Hepatology (1.6k citations), Pharmacology (951 citations), Epidemiology (1.4k citations), Cell Biology (596 citations) and Molecular Biology (2.3k citations). Udayan Apte has collaborated with scholars based in United States, France and China. Frequent co-authors include Satdarshan P. Monga, Chad Walesky, Bharat Bhushan, Pallavi B. Limaye, Kartik Shankar, Tiangang Li, Genea Edwards, Prachi Borude, Vishal S. Vaidya and Benjamin Cieply. Their work appears in journals such as Hepatology, American Journal Of Pathology, The FASEB Journal, Toxicological Sciences and American Journal of Physiology-Gastrointestinal and Liver Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.